Isocitrate dehydrogenase 1 mutation subtypes at site 132 and their translational potential in glioma
Sign Up to like & getrecommendations! Published in 2018 at "CNS Oncology"
DOI: 10.2217/cns-2017-0019
Abstract: In recent years, de novo missense structural mutations in the IDH1 gene of arginine at site 132 (R132) have become a standard for diagnostication and prognostication in glioma management. As our clinical understanding of this… read more here.
Keywords: glioma; mutation subtypes; site 132; translational potential ... See more keywords